Physician profile
Troy Guidry
NPI 1134443138
$644.81
in general payments reported to CMS, 2019-2025
19 companies · $137 in 2025
The $137 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.98 · 2021: $34.45 · 2022: $283 · 2023: $75.42 · 2024: $101 · 2025: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $314.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $313.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $174.99 | 2022 | |
| Novartis Pharmaceuticals Corporation | $46.83 | 2019-2022 | |
| Pfizer INC. | $43.13 | 2024-2025 | |
| Lilly USA, LLC | $41.94 | 2022-2023 | Mounjaro |
| Janssen Biotech, INC. | $38.62 | 2025 | Simponi Aria, Tremfya |
| Mylan Specialty L.P. | $38.30 | 2024 | Yupelri |
| Glaxosmithkline, LLC. | $30.88 | 2022-2023 | Arexvy, Shingrix |
| Janssen Pharmaceuticals, INC | $30.20 | 2022-2023 | Xarelto |
| Xeris Pharmaceuticals, INC. | $24.28 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $23.25 | 2024 | Crysvita |
| Amgen INC. | $23.25 | 2025 | Tezspire |
| Dexcom, INC. | $22.83 | 2025 | Dexcom G6 Transmitter |
| Global Blood Therapeutics, INC. | $21.87 | 2022 | |
| Dynavax Technologies Corporation | $20.34 | 2025 | Heplisav-B |
| Phadia US INC. | $18.24 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $16.73 | 2024 | Freestyle Libre 3 |
| Exact Sciences Corporation | $14.33 | 2023 | Cologuard Collection Kit |
| Phathom Pharmaceuticals, INC. | $11.98 | 2025 | Voquezna |
| Organon LLC | $2.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Troy Guidry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.